Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AstroNova (ALOT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for AstroNova (ALOT) over the last 16 years, with Q4 2025 value amounting to $3.6 million.

  • AstroNova's Cash & Equivalents fell 1863.72% to $3.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.6 million, marking a year-over-year decrease of 1863.72%. This contributed to the annual value of $5.0 million for FY2025, which is 1155.29% up from last year.
  • Per AstroNova's latest filing, its Cash & Equivalents stood at $3.6 million for Q4 2025, which was down 1863.72% from $3.9 million recorded in Q3 2025.
  • Over the past 5 years, AstroNova's Cash & Equivalents peaked at $11.4 million during Q1 2021, and registered a low of $3.6 million during Q4 2025.
  • For the 5-year period, AstroNova's Cash & Equivalents averaged around $5.9 million, with its median value being $4.8 million (2023).
  • As far as peak fluctuations go, AstroNova's Cash & Equivalents surged by 16921.63% in 2021, and later plummeted by 6237.6% in 2022.
  • AstroNova's Cash & Equivalents (Quarter) stood at $8.7 million in 2021, then plummeted by 48.48% to $4.5 million in 2022, then increased by 7.36% to $4.8 million in 2023, then dropped by 8.18% to $4.4 million in 2024, then decreased by 18.64% to $3.6 million in 2025.
  • Its Cash & Equivalents was $3.6 million in Q4 2025, compared to $3.9 million in Q3 2025 and $5.4 million in Q2 2025.